Dawson James analyst Jason Kolbert downgrades BioCardia (NASDAQ:BCDA) from Buy to Neutral.
Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts
Sutro Biopharma (NASDAQ:STRO) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from…